Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Carr

Showing results (11-20 of 155) with videos related to

Pageof 16
Sort By:
Journal of the American Geriatrics Society|March 25, 2000
Subclinical cardiovascular disease and atherosclerosis are not inevitable consequences of agingJ J Carr, G L Burke
Biomedical Instrumentation & Technology|June 27, 2000
Requirements engineering: the key to designing complex medical systemsJ J Carr, C E McCullough
Journal of Virology|August 8, 2008
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient miceManoj Thapa, Daniel J J Carr
Current Topics in Microbiology and Immunology|March 31, 2006
Herpes simplex virus and the chemokines that mediate the inflammationD J J Carr, L Tomanek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Large-scale generation of plasmids that express type I interferonPeter Härle, Daniel J J Carr
The Open Immunology Journal|December 2, 2008
Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) InfectionM Thapa, D J J Carr
Journal of Virology|August 21, 2002
The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferonDaniel J J Carr, Sansanee Noisakran
Mucosal Immunology|December 3, 2015
A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherinD J Royer, D J J Carr
The Journal of Experimental Medicine|December 23, 2009
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesisTodd R Wuest, Daniel J J Carr
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infectionTodd R Wuest, Daniel J J Carr
Pageof 16

Showing results (11-20 of 155) with videos related to

Sort By:
Pageof 16
Journal of the American Geriatrics Society|March 25, 2000
Subclinical cardiovascular disease and atherosclerosis are not inevitable consequences of agingJ J Carr, G L Burke
Biomedical Instrumentation & Technology|June 27, 2000
Requirements engineering: the key to designing complex medical systemsJ J Carr, C E McCullough
Journal of Virology|August 8, 2008
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient miceManoj Thapa, Daniel J J Carr
Current Topics in Microbiology and Immunology|March 31, 2006
Herpes simplex virus and the chemokines that mediate the inflammationD J J Carr, L Tomanek
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Large-scale generation of plasmids that express type I interferonPeter Härle, Daniel J J Carr
The Open Immunology Journal|December 2, 2008
Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) InfectionM Thapa, D J J Carr
Journal of Virology|August 21, 2002
The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferonDaniel J J Carr, Sansanee Noisakran
Mucosal Immunology|December 3, 2015
A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherinD J Royer, D J J Carr
The Journal of Experimental Medicine|December 23, 2009
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesisTodd R Wuest, Daniel J J Carr
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infectionTodd R Wuest, Daniel J J Carr
Pageof 16